Want to know:
A system whereby the CO receives authorization from a fiscal and accounting officer to obligate funds on purchase documents against a specified lump sum of funds reserved for a specified time rather than obtaining individual obligation authority on each purchase document isa. a blanket purchase agreementb. long lead fundingc. bulk fundingd. a charge account.
Get a detailed, AI-powered explanation for this question and thousands more on StudyFetch.
Get the Answer for FreeHow StudyFetch Helps You Master This Topic
AI-Powered Answers
Get instant, detailed explanations powered by AI that understands your course material.
Deep Understanding
Go beyond surface-level answers with step-by-step breakdowns and examples.
Personalized Learning
Spark.E adapts to your learning style and helps you connect ideas.
Practice & Test
Turn any question into flashcards, quizzes, and practice tests to solidify your knowledge.
Explore More Questions
- Describe four differences between the Jovian planets and the Terrestrial planets.a. The Jovian planets are larger and more massive than Terrestrial planets, have much lower densities, don't have natural satellites, their compositions are dominated by carbon and oxygen, while Terrestrials are more rocky and metallic.b. The Jovian planets are larger but less massive than Terrestrial planets, have much lower densities, have rings and multiple moons, their compositions are dominated by methane and ammonia, while Terrestrials consist of primarily carbon and silicon oxides.c. The Jovian planets are larger and more massive than Terrestrial planets, have much higher densities, have rings and multiple moons, their compositions are dominated by helium and water ice, while Terrestrials consist of primarily carbon and silicon oxides.d. The Jovian planets are larger and more massive than Terrestrial planets, have much lower densities, have rings and multiple moons, their compositions are dominated by hydrogen and other gasses, while Terrestrials are more rocky and metallic.
- Ladies Home Journal(magazine), women's trade union
- Candida auris is an emerging fungal pathogen that is associated with nosocomial infections and is considered a serious global health threat. It has numerous virulence qualities and shows multi-drug resistance patterns to common antifungal therapy used for other invasive Candida infections. Yeast identification methods employed by laboratories typically misidentify C. auris as other yeasts making the detection and control of this pathogen difficult. The transmission of Candida auris occurs in nosocomial settings, even in those implementing infection prevention and control measures. In the United States, it is a nationally notifiable pathogen that allows for public health tracking and containing its spread.A 52-year-old male is brought to the emergency department complaining of generalized weakness and fevers. He has a history of type 1 diabetes mellitus with end-stage renal disease and recently started hemodialysis. His vital signs in triage show a temperature of 101.3 F (38.5 C), blood pressure of 82/43 mmHg, heart rate of 99 beats per minute, respiratory rate of 19 breaths per minute, and oxygen saturation of 94% on ambient air. On physical examination, the patient appears weak. The ar